ConductScience.org, home

Paper19252313

Contribution of each amino acid residue in polymyxin B(3) to antimicrobial and lipopolysaccharide binding activity.

Kanazawa K and 6 others. Chem Pharm Bull (Tokyo), 2009. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Contribution of each amino acid residue in polymyxin B(3) to antimicrobial and lipopolysaccharide binding activity. Papers, record 19252313. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19252313

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Contribution of each amino acid residue in polymyxin B(3) to antimicrobial and lipopolysaccharide binding activity.
PubMed
Journal
Chem Pharm Bull (Tokyo)
PubMed
Year
2009
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
1.8
iCite
Revised in PubMed
2019-07-06
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kanazawa KKazushi
2Sato YYuki
3Ohki KKazuhiro
4Okimura KKeiko
5Uchida YYoshiki
6Shindo MMitsuno
7Sakura NNaoki

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
LipopolysaccharidesMajor topic
Alanine
Amino Acid Sequence
Hydrophobic and Hydrophilic Interactions
Microbial Sensitivity Tests
Polymyxin B
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
41169568Structure-Activity Relationship of the Diaminobutyric Acid Residues in Polymyxins.JACS Au2025https://conductscience.org/library/papers/41169568PubMed
40980911Noncytotoxic polymyxin derivatives enhance antibiotic action against multidrug-resistant Gram-negative bacteria.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/40980911PubMed
39825802Role of Divalent Ions in Membrane Models of Polymyxin-Sensitive and Resistant Gram-Negative Bacteria.J Chem Inf Model2025https://conductscience.org/library/papers/39825802PubMed
39344345Evaluation and Molecular Characterization of Colistin-Resistant Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae from the Infected Wounds of Hospitalized Patients.J Microbiol Biotechnol2024https://conductscience.org/library/papers/39344345PubMed
38674716A Review on Colistin Resistance: An Antibiotic of Last Resort.Microorganisms2024https://conductscience.org/library/papers/38674716PubMed
37071814Linearization of the Brevicidine and Laterocidine Lipopeptides Yields Analogues That Retain Full Antibacterial Activity.J Med Chem2023https://conductscience.org/library/papers/37071814PubMed
35964158Polymyxins induce lipid scrambling and disrupt the homeostasis of Gram-negative bacteria membrane.Biophys J2022https://conductscience.org/library/papers/35964158PubMed
35946799Synergy by Perturbing the Gram-Negative Outer Membrane: Opening the Door for Gram-Positive Specific Antibiotics.ACS Infect Dis2022https://conductscience.org/library/papers/35946799PubMed
35335864Functional Polymers as Innovative Tools in the Delivery of Antimicrobial Agents.Pharmaceutics2022https://conductscience.org/library/papers/35335864PubMed
34667587A novel chemical biology and computational approach to expedite the discovery of new-generation polymyxins against life-threatening Acinetobacter baumannii.Chem Sci2021https://conductscience.org/library/papers/34667587PubMed
33532575Stereorandomization as a Method to Probe Peptide Bioactivity.ACS Cent Sci2021https://conductscience.org/library/papers/33532575PubMed
33495702Molecular engineering of antimicrobial peptides: microbial targets, peptide motifs and translation opportunities.Biophys Rev2021https://conductscience.org/library/papers/33495702PubMed
33458490Molecular Dynamics Simulation of the Interaction of Two Linear Battacin Analogs with Model Gram-Positive and Gram-Negative Bacterial Cell Membranes.ACS Omega2021https://conductscience.org/library/papers/33458490PubMed
33187332Bi-Functional Alginate Oligosaccharide-Polymyxin Conjugates for Improved Treatment of Multidrug-Resistant Gram-Negative Bacterial Infections.Pharmaceutics2020https://conductscience.org/library/papers/33187332PubMed
32630683Identification of Genetic Alterations Associated with Acquired Colistin Resistance in Klebsiella pneumoniae Isogenic Strains by Whole-Genome Sequencing.Antibiotics (Basel)2020https://conductscience.org/library/papers/32630683PubMed
32311341How do cyclic antibiotics with activity against Gram-negative bacteria permeate membranes? A machine learning informed experimental study.Biochim Biophys Acta Biomembr2020https://conductscience.org/library/papers/32311341PubMed
32077828Therapeutic Strategies to Protect the Central Nervous System against Shiga Toxin from Enterohemorrhagic Escherichia coli.Curr Neuropharmacol2021https://conductscience.org/library/papers/32077828PubMed
31525992Design of Next Generation Polymyxins with Lower Toxicity: The Discovery of SPR206.ACS Infect Dis2019https://conductscience.org/library/papers/31525992PubMed
30793045Membrane charge and lipid packing determine polymyxin-induced membrane damage.Commun Biol2019https://conductscience.org/library/papers/30793045PubMed
30588791Design, Synthesis, and Nanostructure-Dependent Antibacterial Activity of Cationic Peptide Amphiphiles.ACS Appl Mater Interfaces2019https://conductscience.org/library/papers/30588791PubMed

See all 28 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19252313

GET https://conductscience.org/api/papers/v1/19252313/cited_by?page=2